Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: An in vivo study1

Neoplasia

Volumn 13, Issue 7, 2011, Pages 620-632

  Colen, Chaim B ^a   Shen, Yimin ^a   Ghoddoussi, Farhad ^a   Yu, Pingyang ^a   Francis, Todd B ^a   Koch, Brandon J ^b   Monterey, Michael D ^a   Galloway, Matthew P ^a   Sloan, Andrew E ^c   Mathupala, Saroj P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROLLINS COLLEGE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CYANO 4 HYDROXYCINNAMIC ACID; LACTIC ACID; MONOCARBOXYLATE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CANCER INHIBITION; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; GLIOBLASTOMA; GLIOMA CELL; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOCHONDRIAL RESPIRATION; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOTIC PUMP; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SURVIVAL RATE; TUMOR NECROSIS;

EID: 79960039507     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.11134     Document Type: Article

References (61)

1. Warburg O, Dickens F, and Kaiser Wilhelm-Institut fur Biologie B (1930). The Metabolism of Tumours: Investigations from the Kaiser-Wilhelm Institute for Biology, Berlin-Dahlem. Constable & Co, Ltd, London, UK.
2. Baggetto LG (1992). Deviant energetic metabolism of glycolytic cancer cells. Biochimie 74, 959-974.
3. Pedersen PL (1978). Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res 22, 190-274.
4. Walenta S, Schroeder T, and Mueller-Klieser W (2004). Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr Med Chem 11, 2195-2204.
5. Walenta S and Mueller-Klieser WF (2004). Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol 14, 267-274.
6. Halestrap AP and Price NT (1999). The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 343(Pt 2), 281-299.
7. Halestrap AP and Meredith D (2004). The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 447, 619-628.
8. Mathupala SP, Parajuli P, and Sloan AE (2004). Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: an in vitro study. Neurosurgery 55, 1410-1419; discussion 1419.
9. Froberg MK, Gerhart DZ, Enerson BE, Manivel C, Guzman-Paz M, Seacotte N, and Drewes LR (2001). Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues. Neuroreport 12, 761-765.
10. Mac M and Nalecz KA (2003). Expression of monocarboxylic acid transporters (MCT) in brain cells. Implication for branched chain α-ketoacids transport in neurons. Neurochem Int 43, 305-309.
11. Chiry O, Fishbein WN, Merezhinskaya N, Clarke S, Galuske R, Magistretti PJ, and Pellerin L (2008). Distribution of the monocarboxylate transporter MCT2 in human cerebral cortex: an immunohistochemical study. Brain Res 1226, 61-69.
12. Chiry O, Pellerin L, Monnet-Tschudi F, Fishbein WN, Merezhinskaya N, Magistretti PJ, and Clarke S (2006). Expression of the monocarboxylate transporter MCT1 in the adult human brain cortex. Brain Res 1070, 65-70.
13. Colen CB, Seraji-Bozorgzad N, Marples B, Galloway MP, Sloan AE, and Mathupala SP (2006). Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study. Neurosurgery 59, 1313-1323; discussion 1323-1314.
14. Coss RA, Storck CW, Daskalakis C, Berd D, and Wahl ML (2003). Intracellular acidification abrogates the heat shock response and compromises survival of human melanoma cells. Mol Cancer Ther 2, 383-388.
15. +-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma. Mol Pharmacol 70, 2108-2115.
16. Mathupala SP, Colen CB, Parajuli P, and Sloan AE (2007). Lactate and malignant tumors: a therapeutic target at the end stage of glycolysis. J Bioenerg Biomembr 39, 73-77.
17. Spencer TL and Lehninger AL (1976). L-Lactate transport in Ehrlich ascitestumour cells. Biochem J 154, 405-414.
18. Sonveaux P, Vegran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, et al. (2008). Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118, 3930-3942.
19. Sattler UG, Meyer SS, Quennet V, Hoerner C, Knoerzer H, Fabian C, Yaromina A, Zips D, Walenta S, Baumann M, et al. (2010). Glycolytic metabolism and tumour response to fractionated irradiation. Radiother Oncol 94, 102-109.
20. Pellerin L and Magistretti PJ (2004). Neuroscience. Let there be (NADH) light. Science 305, 50-52.
21. Kasischke KA, Vishwasrao HD, Fisher PJ, Zipfel WR, and Webb WW (2004). Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 305, 99-103.
22. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, and McEwan RN (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47, 3239-3245.
23. Platet N and Garcia M (1998). A new bioassay using transient transfection for invasion-related gene analysis. Invasion Metastasis 18, 198-208.
24. Jung S, Kim HW, Lee JH, Kang SS, Rhu HH, Jeong YI, Yang SY, Chung HY, Bae CS, Choi C, et al. (2002). Brain tumor invasion model system using organotypic brain-slice culture as an alternative to in vivo model. J Cancer Res Clin Oncol 128, 469-476.
25. Ohnishi T, Matsumura H, Izumoto S, Hiraga S, and Hayakawa T (1998). A novel model of glioma cell invasion using organotypic brain slice culture. Cancer Res 58, 2935-2940.
26. Mathupala SP (2001). Bicistronic Retroviral Vector pLXRN (Accession No. AF113968), GenBank. National Center for Biotechnology Information.
27. Miller AD and Buttimore C (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6, 2895-2902.
28. Miller AD, Trauber DR, and Buttimore C (1986). Factors involved in production of helper virus-free retrovirus vectors. Somat Cell Mol Genet 12, 175-183.
29. Paxinos G and Watson C (1998). The Rat Brain in Stereotaxic Coordinates (4th ed). Academic Press, San Diego, CA.
30. Wiegand R, Wu J, Sha X, LoRusso P, Heath E, and Li J (2009). Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate aminoflavone (NSC 686288) in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 877, 1460-1464.
31. Paxinos G and Watson C (2007). The Rat Brain in Stereotaxic Coordinates (6th ed). Academic Press/Elsevier, Amsterdam, Netherlands.
32. Ghoddoussi F, Galloway MP, Jambekar A, Bame M, Needleman R, and Brusilow WS (2010). Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS. J Neurol Sci 290, 41-47.
33. Provencher SW (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30, 672-679.
34. Kaplan EL and Meier P (1958). Nonparametric estimator from incomplete observations. J Am Stat Assoc 53, 457-481.
35. Halestrap AP and Denton RM (1975). The specificity and metabolic implications of the inhibition of pyruvate transport in isolated mitochondria and intact tissue preparations by α-cyano-4-hydroxycinnamate and related compounds. Biochem J 148, 97-106.
36. Colen CB (2005). Gene Therapy and Radiation of Malignant Glioma by Targeting Glioma Specific Lactate Transporter. Neurological Surgery and Physiology, Wayne State University School of Medicine, Detroit, MI.
37. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, and Oldfield EH (1994). Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 91, 2076-2080.
38. Chen MY, Lonser RR, Morrison PF, Governale LS, and Oldfield EH (1999). Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissuecannula sealing time. J Neurosurg 90, 315-320.
39. Degen JW, Walbridge S, Vortmeyer AO, Oldfield EH, and Lonser RR (2003). Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg 99, 893-898.
40. Burkitt HG, Young B, Heath JW, and Wheater PR (1993). Wheater's Functional Histology: A Text and Colour Atlas (3rd ed). Churchill Livingstone, Edinburgh, UK.
41. Gredell JA, Turnquist PA, MacIver MB, and Pearce RA (2004). Determination of diffusion and partition coefficients of propofol in rat brain tissue: implications for studies of drug action in vitro. Br J Anaesth 93, 810-817.
42. Wahl ML, Owen JA, Burd R, Herlands RA, Nogami SS, Rodeck U, Berd D, Leeper DB, and Owen CS (2002). Regulation of intracellular pH in human melanoma: potential therapeutic implications. Mol Cancer Ther 1, 617-628.
43. Pinheiro C, Reis RM, Ricardo S, Longatto-Filho A, Schmitt F, and Baltazar F (2010). Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. J Biomed Biotechnol 2010, 427694.
44. Pierre K and Pellerin L (2005). Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem 94, 1-14.
45. Pellerin L, Bergersen LH, Halestrap AP, and Pierre K (2005). Cellular and subcellular distribution of monocarboxylate transporters in cultured brain cells and in the adult brain. J Neurosci Res 79, 55-64.
46. Philp NJ, Yoon H, and Lombardi L (2001). Mouse MCT3 gene is expressed preferentially in retinal pigment and choroid plexus epithelia. Am J Physiol Cell Physiol 280, C1319-C1326.
47. Halestrap AP and Denton RM (1974). Specific inhibition of pyruvate transport in rat liver mitochondria and human erythrocytes by α-cyano-4-hydroxycinnamate. Biochem J 138, 313-316.
48. Hildyard JC, Ammala C, Dukes ID, Thomson SA, and Halestrap AP (2005). Identification and characterisation of a new class of highly specific and potent inhibitors of the mitochondrial pyruvate carrier. Biochim Biophys Acta 1707, 221-230.
49. Ovens MJ, Davies AJ, Wilson MC, Murray CM, and Halestrap AP (2010). ARC155858 is a potent inhibitor of monocarboxylate transportersMCT1 andMCT2 that binds to an intracellular site involving transmembrane helices 7-10. Biochem J 425, 523-530.
50. Rae C, Nasrallah FA, and Broer S (2009). Metabolic effects of blocking lactate transport in brain cortical tissue slices using an inhibitor specific to MCT1 and MCT2. Neurochem Res 34, 1783-1791.
51. Valster A, Tran NL, Nakada M, Berens ME, Chan AY, and Symons M (2005). Cell migration and invasion assays. Methods 37, 208-215.
52. Stern R, Shuster S, Neudecker BA, and Formby B (2002). Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited. Exp Cell Res 276, 24-31.
53. Bellail AC, Hunter SB, Brat DJ, Tan C, and Van Meir EG (2004). Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36, 1046-1069.
54. Baumann F, Leukel P, Doerfelt A, Beier CP, Dettmer K, Oefner PJ, Kastenberger M, Kreutz M, Nickl-Jockschat T, Bogdahn U, et al. (2009). Lactate promotes glioma migration by TGF-ß2-dependent regulation of matrix metalloproteinase-2. Neuro Oncol 11, 368-380.
55. Gatenby RA, Gawlinski ET, Gmitro AF, Kaylor B, and Gillies RJ (2006). Acidmediated tumor invasion: a multidisciplinary study. Cancer Res 66, 5216-5223.
56. Smallbone K, Gatenby RA, Gillies RJ, Maini PK, and Gavaghan DJ (2007). Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol 244, 703-713.
57. Gatenby RA and Gawlinski ET (2003). The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Res 63, 3847-3854.
58. Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, et al. (2009). Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 69, 2260-2268.
59. Khan A, Jallo GI, Liu YJ, Carson BS Sr, and Guarnieri M (2005). Infusion rates and drug distribution in brain tumor models in rats. J Neurosurg 102, 53-58.
60. + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11, 37-51.
61. Michelakis ED, Sutendra G, Dromparis P, Webster L, Haromy A, Niven E, Maguire C, Gammer TL, Mackey JR, Fulton D, et al. (2010). Metabolic modulation of glioblastoma with dichloroacetate. Sci Transl Med 2, 31ra34.